testosterone

* Testosterone plays an important role in the maintenance of male skeleton. Most studies of testosterone therapy have demonstrated some degree of improvement in BMD * Based on elegant mechanistic studies (discussed below), the current thinking is that both testosterone and estradiol are...

In part one of this men’s health series, Dr. Eve Glazier and Jesse Mills, MD, health sciences clinical professor of urology and director of the Men’s Health Clinic at UCLA Health, examine how symptoms such as erectile dysfunction can offer important insights into overall health. They discuss why...

* Bhasin noted that, like fellow academics and endocrinologists, he has historically been cautious around testosterone therapy. “In the last 5 years or so, we’ve learned a lot more, and I’ve changed my position,” he said. “On one side, it’s very rigid, and on the other, it’s touted as the cure...

Who knew LOL! * Rena Malik, MD brings together leading experts Dr. Helen Bernie, Dr. James Smith, and Chief Medical Advisor of Swim Club Dr. Michael Eisenberg to discuss male infertility, declining sperm counts, and how lifestyle factors impact reproductive health. In this episode, Rena...

In this episode, Dr. Brandon and Dr. Morgentaler talk about the FDA's groundbreaking testosterone label changes, the evolving evidence on testosterone therapy and prostate cancer, and how quality of life should factor into treatment decisions for men with advanced disease. Time stamps...

Sanoj Punnen, MD, highlights the importance of assessing and managing cardiovascular risk when initiating androgen deprivation therapy for patients with prostate cancer.

The FDA's proposed narrowing of the testosterone therapy prostate cancer contraindication to metastatic disease only reflects current clinical evidence, opening the door to testosterone therapy in appropriately selected men with treated localized prostate cancer or on active surveillance, with...

In this episode of AUANews Inside Tract, host Dr. Mark Edney speaks with Dr. Helen Burnie about the FDA’s proposed updates to testosterone therapy labeling and what they could mean for urologists, patients, and the broader field of men’s health. The discussion explores new evidence on...

* For women, clinical discussions are currently underway with the FDA to bring regulatory approval for female-specific testosterone gels and oral formats to the US market within the next two to three years. There is an undeniable buzz around testosterone for women right now. While many...

In conclusion, men with lower testosterone concentrations had higher risk of cancer death, and men with mid-range SHBG or luteinising hormone concentrations had lower risk. Low testosterone concentrations were associated with risk of any fatal or non-fatal incident cancer. Men with lower SHBG or...

* This narrative review integrates randomized and real‑world evidence on TRT‑associated AF, AKI, and PE, translates these signals into practical guidance for patient selection and safety monitoring, and outlines key methodological and mechanistic priorities for future research. In contemporary...

In this episode, Shalin Shah, CEO of Marius Pharmaceuticals and a passionate advocate for testosterone education, shares insights on the misunderstood hormone that impacts both men and women. We dive into myths, testing protocols, treatment options, and the importance of early diagnosis for...

* The survey found that the most commonly reported symptoms over the past year (among those tested) included low energy or fatigue (48%), poor sleep (47%), reduced motivation (34%), low sex drive (28%), mood changes or irritability (27%), brain fog (26%), weight gain (26%), and reduced muscle...

Nature staff discuss preliminary data on the effects of GLP-1 drugs on male fertility, plus a two-year trial of a brain-computer interface. Timestamps 00:18 Brain-computer interface makes a life-changing impactNature: At-home brain implant gives man with motor neuron disease his daily life...

* We devised a formula to calculate predicted total testosterone concentrations, based on meta-analyses of individual participant data from 21,074 men, aged 17-99 years, from nine cohort studies in Australia, Europe and North America of community-dwelling men with testosterone measured using...

https://www.hhs.gov/press-room/fda-requests-updates-testosterone-therapy-labeling.html The U.S. Department of Health and Human Services, through the U.S. Food and Drug Administration (FDA), announced today that it is requesting updates to the prescribing information for testosterone...

Must listen here! Most men think erectile dysfunction is a bedroom problem and low testosterone is just a fact of getting older. This roundtable makes the case that both are early warning lights for your heart, your metabolism, and your long-term health and that ignoring them can cost...

Powerhouse in the field! In this episode, Dr. Brandon and Dr. Morgentaler welcome Dr. Abdulmaged Traish, world-renowned hormone researcher and professor emeritus at Boston University, to talk about his incredible journey from growing up in a poor village with no electricity or running...

Curated By Nelson Vergel | ExcelMale.com | Updated June 2026 If you've been on TRT for a while and still deal with flat libido or low motivation - even with testosterone in a solid range - there may be more happening than your T levels alone can explain. One underappreciated piece of that...

Dr. Arthur Burnett discusses the way in which men traditionally have approached their health and talks about manners in which they may reframe their thinking.

Most men think erectile dysfunction is a bedroom problem. It's actually one of the earliest warning signs of cardiovascular disease, capable of showing up three to five years before a heart attack.In this episode, Dr. Gabrielle Lyon sits down with Dr. Amy Pearlman, a urologist trained in...

Start low and go slow, where have we heard that one before LOL! https://www.contemporaryobgyn.net/view/individualized-trt-demonstrates-broad-symptom-improvements-beyond-sexual-function Testosterone replacement therapy (TRT) in women may offer multidimensional symptom improvement...

My neck of the woods. One of the heavyweights in the field! Been at it for decades! Presented by: Dr. Shehzad Basaria Objectives: • To understand the Physiology of the Hypothalamic-Pituitary-Gondal Axis • To become familiar with various Etiologies of Male Hypogonadism •...

You've watched him pull away and wondered if something is actually wrong with his body — and you were right to wonder. Dr. Arthur Burnett, Johns Hopkins urologist, breaks down exactly what testosterone does (and doesn't) do for men's drive, erections, and mood — and why a basic blood test isn't...

In this episode of Pearls & Perspectives, Amy Pearlman, MD, is joined by Larry I. Lipschultz, MD, to discuss the growing interest in peptides, including their potential applications in men’s health, evolving regulatory landscape, and what urologists need to know as patient demand continues to...

, discusses : : . ,

* Overall, the available evidence suggests that TRT may provide clinically meaningful improvements in mood for hypogonadal men, particularly those with low baseline testosterone and coexisting depressive symptoms. However, current data do not support its routine use as an antidepressant therapy...

Curated By Nelson Vergel | ExcelMale.com | Updated May 2026 Most men assume their penis will stay exactly as they remember it from their 20s. Then, somewhere in their 40s or 50s, things start to feel different. The erections are not quite as firm, morning wood has become less reliable, and a...

Dr. Andres Guillen Lozoya discusses findings from, "Testosterone Levels Improve in Men under GLP-1 Receptor Agonist Therapy.” This study aimed to evaluate changes in total and free testosterone before and after GLP-1RA therapy in men

* In male infants, luteinizing hormone (LH) and testosterone during minipuberty are present at levels similar to those in adults but subsequently become undetectable. This phenomenon was shown in infant boys more than 50 years ago. https://www.nejm.org/doi/full/10.1056/NEJMra2305989

Speakers: Prof. J-N.L. Cornu (FR) Dr. M. Tutolo (IT) Dr. D. Elterman (CA) M. Creta, Naples (IT) This recording explores a holistic, patient-centred approach to male lower urinary tract symptoms (LUTS) beyond single-symptom treatment strategies. Male LUTS are common, heterogeneous, and...